Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
Epub 2011 Sep 22
so it has IC50 >1 µM for inhibiting demthylation of H3K4 in U2OS human osteosarcoma cell line and in human breast adenocarcinoma MCF7 tumor cell proliferation assay
ISRIB blocks multiple stress effectors
Valizadeh-Arshad Z
CPI-444 - CAS# 1202402-40-1 0101 Epub 2011 Sep 22CPI 444, CAS No. 1202402 40 1, is an orally administered antagonist of the adenosine A2A receptor. Upon oral administration, CPI 444 binds to adenosine A2A receptors expressed on the surface of immune cells, including T lymphocytes, natural killer (NK) cells, macrophages and dendritic cells (DCs). This prevents tumor released adenosine from interacting with the A2A receptors on these key immune surveillance cells, thereby abrogating adenosine induced
US$ 79.00
US$ 150.00
US$ 79.00
US$ 22.30
US$ 250.00